TOPIC
bharat biotech
‘India’s low-cost vaccines have rescued the world’: Top US scientist says India’s efforts need wider recognition
American Scientist Dr Hortez said India's COVID-19 vaccine rollout has 'rescued the world' by providing a large supply of low-cost vaccines.
Bharat Biotech’s Covaxin shows 81% efficacy, phase 3 trials with 25,800 subjects completed
The phase 3 trials involved 25,800 subjects. The trial, done in collaboration with ICMR, is the largest ever clinical trial done in India.
The second phase of Covid-19 vaccination starts today: Here is all you need to know about registering in Co-Win 2.0 portal
Covid Vaccination program's next phase commenced on March 1, 2021. PM Modi also took Bharat Biotech's vaccine Covaxin today.
PM Modi takes the first dose of Made-in-India Bharat Biotech’s COVAXIN vaccine as second phase of Covid-19 vaccination starts
PM Modi waited for the second phase of vaccination to begin as while he is a senior citizen, the first phase of vaccination was for frontline workers, like doctors, nurses and others who are more vulnerable to catching the virus.
India becomes the fastest country to administer 1 million doses of Covid-19 vaccine in just 6 days
India has left the US behind by crossing the million mark in just six days as compared to nine days taken by the US.
Bharat Biotech’s ‘Covaxin’ is safe, vaccine led to enhanced immune responses to Covid-19, says medical journal Lancet
The prestigious medical journal said that Covaxin generated tolerable safety outcomes and enhanced immune responses.
India sends Covid-19 vaccines to all neighbouring countries except Pakistan, China steps in to aid Pakistan with free Chinese vaccine
India has not sent any vaccines to Pakistan, and there are no reports suggesting that Indian govt will send any vaccine to them
Vaccine not to be administered to people below 18 years, pregnant and lactating women kept out of COVID vaccination drive
Earlier, Covaxin was approved for children above 12, while SII's Covishield was approved for persons above 18. The new order states that Covaxin will also be administered only to persons above 18.
COVID-19 vaccination: Serum Institute receives purchase order for 11 million doses from Govt of India
Covishield vaccine produced by the Seru Institute of India to be available at Rs 200 per dose.
‘Cause of death is poisoning, not vaccine’: Bharat Biotech issues clarification after phase 3 trial participant for Covaxin dies in Bhopal
The volunteer from Bhopal in Madhya Pradesh had died 10 days after he had participated in the clinical trial for Covaxin
